These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23887074)

  • 41. Length of the follicular growing phase and oocyte competence in beef heifers.
    Dias FC; Dadarwal D; Adams GP; Mrigank H; Mapletoft RJ; Singh J
    Theriogenology; 2013 May; 79(8):1177-1183.e1. PubMed ID: 23534995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Withdrawal of GnRH agonist decreases oestradiol and VEGF concentrations in high responders.
    Ding LJ; Wang B; Shen XY; Yan GJ; Zhang NY; Hu YL; Sun HX
    Reprod Biomed Online; 2013 Aug; 27(2):131-9. PubMed ID: 23764202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evaluation of prophylactic approach to reduce incidence of ovarian hyperstimulation syndrome in in vitro fertilization].
    Fukuda J; Kodama H; Matsui T; Shimizu Y; Karube H; Tanaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Oct; 47(10):1071-4. PubMed ID: 8522886
    [No Abstract]   [Full Text] [Related]  

  • 45. Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome--a 20-year experience.
    Kol S; Itskovitz-Eldor J
    Semin Reprod Med; 2010 Nov; 28(6):500-5. PubMed ID: 21082509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Agonist trigger: what is the best approach? Agonist trigger and low dose hCG.
    Humaidan P
    Fertil Steril; 2012 Mar; 97(3):529-30. PubMed ID: 22154368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro oocyte maturation: current status.
    Nogueira D; Sadeu JC; Montagut J
    Semin Reprod Med; 2012 Jun; 30(3):199-213. PubMed ID: 22585631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 'GnRH agonist trigger: looking for the coin under the lamp post?'.
    Kol S
    Hum Reprod; 2006 May; 21(5):1328; author reply 1328-9. PubMed ID: 16611976
    [No Abstract]   [Full Text] [Related]  

  • 50. Agonist and antagonist coast.
    Aboulghar M
    Fertil Steril; 2012 Mar; 97(3):523-6. PubMed ID: 22265033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention and management of ovarian hyperstimulation syndrome.
    Chen CD; Chen SU; Yang YS
    Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):817-27. PubMed ID: 22647872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
    Orvieto R; Kruchkovich J; Rabinson J; Zohav E; Anteby EY; Meltcer S
    Fertil Steril; 2008 Jul; 90(1):228-30. PubMed ID: 17681292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new treatment to avoid severe ovarian hyperstimulation utilizing insights from in vitro maturation therapy.
    Rose BI
    J Assist Reprod Genet; 2014 Feb; 31(2):195-8. PubMed ID: 24293115
    [No Abstract]   [Full Text] [Related]  

  • 54. Ovarian hyperstimulation syndrome.
    Lancet; 1991 Nov; 338(8775):1111-2. PubMed ID: 1682546
    [No Abstract]   [Full Text] [Related]  

  • 55. Ovarian hyperstimulation syndrome: acute onset dyspnea in a young woman.
    Garrett CW; Gaeta TJ
    Am J Emerg Med; 2002 Jan; 20(1):63-4. PubMed ID: 11781924
    [No Abstract]   [Full Text] [Related]  

  • 56. Authors' reply.
    Lainas TG; Kolibianakis EM
    BJOG; 2015 Mar; 122(4):585-6. PubMed ID: 25702542
    [No Abstract]   [Full Text] [Related]  

  • 57. Turn, turn, turn.
    Evers JL
    Hum Reprod; 2013 Sep; 28(9):2313-4. PubMed ID: 23887074
    [No Abstract]   [Full Text] [Related]  

  • 58. Low-dose hCG supplementation after GnRH agonist triggering: Don't be too quick on the trigger.
    Bodri D
    Hum Reprod; 2013 Sep; 28(9):2315-7. PubMed ID: 23633554
    [No Abstract]   [Full Text] [Related]  

  • 59. Risk factors for ovarian hyperstimulation syndrome: relevance of the number of follicles, serum estradiol levels and the number of oocytes collected.
    Ata B; Seyhan A; Polat M; Young Son W; Yarali H; Dahan M
    Hum Reprod; 2013 Sep; 28(9):2595. PubMed ID: 23838158
    [No Abstract]   [Full Text] [Related]  

  • 60. Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting.
    DiLuigi AJ; Engmann L; Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
    Fertil Steril; 2010 Aug; 94(3):1111-4. PubMed ID: 20074722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.